{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:39:49Z","timestamp":1775641189691,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cld.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T12:16:53Z","timestamp":1463228213000},"page":"491-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prognosis and Prognostic Scoring Models for Alcoholic Liver Disease and Acute Alcoholic Hepatitis"],"prefix":"10.1016","volume":"20","author":[{"given":"Pierre M.","family":"Gholam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cld.2016.02.007_bib1","first-page":"484","article-title":"APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF)","volume":"14","author":"Duseja","year":"2013","journal-title":"J\u00a0Dig Dis"},{"issue":"2","key":"10.1016\/j.cld.2016.02.007_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2016.02.007_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2016.02.007_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2016.02.007_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2016.02.007_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2016.02.007_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2016.02.007_bib8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/gut.2004.063420","article-title":"Predicting mortality by the Glasgow alcoholic hepatitis score: the long awaited progress?","volume":"54","author":"Tilg","year":"2005","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cld.2016.02.007_bib9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cld.2016.02.007_bib10","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2016.02.007_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ajg.2009.645","article-title":"Comparison of the Glasgow alcoholic hepatitis score and the ABIC score for the assessment of alcoholic hepatitis","volume":"105","author":"Forrest","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"10.1016\/j.cld.2016.02.007_bib12","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.cld.2016.02.007_bib13","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2016.02.007_bib14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3109\/00365521.2011.587200","article-title":"Validation of prognostic scores for clinical use in patients with alcoholic hepatitis","volume":"46","author":"Sandahl","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2016.02.007_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12654","article-title":"Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort","volume":"39","author":"Papastergiou","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2016.02.007_bib16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2016.02.007_bib17","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2016.02.007_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2016.02.007_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","article-title":"Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial","volume":"50","author":"Sharma","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2016.02.007_bib20","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s10620-012-2097-4","article-title":"Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial)","volume":"57","author":"Sidhu","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.cld.2016.02.007_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.cld.2016.02.007_bib22","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2016.02.007_bib23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2016.02.007_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2016.02.007_bib25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","article-title":"Risk factors for mortality after surgery in patients with cirrhosis","volume":"132","author":"Teh","year":"2007","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2016.02.007_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2016.02.007_bib27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"125","key":"10.1016\/j.cld.2016.02.007_bib28","first-page":"1089","article-title":"Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis","volume":"60","author":"Monsanto","year":"2013","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2016.02.007_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T17:38:17Z","timestamp":1567877897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116300071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1089326116300071"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.02.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis and Prognostic Scoring Models for Alcoholic Liver Disease and Acute Alcoholic Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}